USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observations

New Delhi: Jubilant Pharmova Ltd on Friday said the US health regulator has completed an inspection of the contract manufacturing facility of its group firm Jubilant HollisterStier LLC located in Spokane, USA, with eight observations.

The US Food and Drug Administration (USFDA) has concluded an inspection of Jubilant HollisterStier LLC (JHS)'s contract manufacturing facility located in Spokane, Washington on June 17, 2026, Jubilant Pharmova said in a regulatory filing.

Read more: FDA expands recall to all Clover Hill Dairy cheeses after listeria found in products and facility

"The USFDA had issued eight observations, none of which are related to sterility assurance concerns," it added.

JHS will respond to the inspection observations within 15 business days. The company is committed to addressing the observations comprehensively, the filing said.

Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc, which is a subsidiary of Jubilant Pharma Ltd, Singapore, a wholly-owned subsidiary of the company, Jubilant Pharmova said.

Read more: Over 58,000 cases of Aldi's Park Street Deli macaroni & cheese recalled nationwide due to undeclared soy

Read more at:

https://economictimes.indiatimes.com/us/news/aldis-park-street-deli-macaroni-cheese-recalled-nationwide-due-to-undeclared-soy/articleshow/131731000.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst